Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Marberger

Showing results (21-30 of 145) with videos related to

Pageof 15
Sort By:
Current Opinion in Urology|February 16, 2006
Incontinence after radical prostatectomy: surgical treatment optionsH Christoph Klingler, Michael Marberger
European Urology|December 18, 2009
Open to debate. The motion: GnRH antagonists are the new way forward in hormonal therapyNoel W Clarke, Michael Marberger
The Urologic Clinics of North America|May 9, 2003
When to biopsy and when to stop biopsyingBob Djavan, Mesut Remzi, Michael Marberger
Archivos Espanoles De Urologia|February 15, 2013
New ablative treatments for small renal masses: HIFU ablationChristoph Klingler, Markus Margreiter, Michael Marberger
Current Opinion in Urology|December 26, 2001
Morphological and biological predictors for treatment outcome of transurethral microwave thermotherapyChristian Seitz, Bob Djavan, Michael Marberger
European Urology|December 22, 2006
Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?Gero Kramer, Dieter Mitteregger, Michael Marberger
Human Pathology|September 3, 2004
Prognostic factors in Bilharzial-related bladder cancerMartin Susani, Andrea Haitel, Michael Marberger
BJU International|October 20, 2010
Low serum testosterone levels are poor predictors of sexual dysfunctionMichael Marberger, Timothy H Wilson, Roger S Rittmaster
Current Opinion in Urology|April 20, 2004
Benign prostatic hyperplasia progression and its impact on treatmentBob Djavan, Matthias Waldert, Clemens Ghawidel, et al.
The Journal of Urology|April 8, 2006
Clinical usefulness of serum prostate specific antigen for the detection of prostate cancer is preserved in men receiving the dual 5alpha-reductase inhibitor dutasterideGerald L Andriole, Michael Marberger, Claus G Roehrborn
Pageof 15

Showing results (21-30 of 145) with videos related to

Sort By:
Pageof 15
Current Opinion in Urology|February 16, 2006
Incontinence after radical prostatectomy: surgical treatment optionsH Christoph Klingler, Michael Marberger
European Urology|December 18, 2009
Open to debate. The motion: GnRH antagonists are the new way forward in hormonal therapyNoel W Clarke, Michael Marberger
The Urologic Clinics of North America|May 9, 2003
When to biopsy and when to stop biopsyingBob Djavan, Mesut Remzi, Michael Marberger
Archivos Espanoles De Urologia|February 15, 2013
New ablative treatments for small renal masses: HIFU ablationChristoph Klingler, Markus Margreiter, Michael Marberger
Current Opinion in Urology|December 26, 2001
Morphological and biological predictors for treatment outcome of transurethral microwave thermotherapyChristian Seitz, Bob Djavan, Michael Marberger
European Urology|December 22, 2006
Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?Gero Kramer, Dieter Mitteregger, Michael Marberger
Human Pathology|September 3, 2004
Prognostic factors in Bilharzial-related bladder cancerMartin Susani, Andrea Haitel, Michael Marberger
BJU International|October 20, 2010
Low serum testosterone levels are poor predictors of sexual dysfunctionMichael Marberger, Timothy H Wilson, Roger S Rittmaster
Current Opinion in Urology|April 20, 2004
Benign prostatic hyperplasia progression and its impact on treatmentBob Djavan, Matthias Waldert, Clemens Ghawidel, et al.
The Journal of Urology|April 8, 2006
Clinical usefulness of serum prostate specific antigen for the detection of prostate cancer is preserved in men receiving the dual 5alpha-reductase inhibitor dutasterideGerald L Andriole, Michael Marberger, Claus G Roehrborn
Pageof 15